← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Akrotome Imaging, Inc.
Charlotte, NC
$4,147,784
Total funding
5
Grants
Funding over time
peak $995.6K · FY2011–23$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,147,784 · 5
By mechanism
R44$3,466,324 · 2
R43$431,548 · 2
N43$249,912 · 1
Investigators at Akrotome Imaging, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Along the continuum for an IND: An In-Vivo large animal study for opticalimage guided surgery of spontaneous breast cancer.$995,636
R44 · FY2022 · CA
Intraoperative assessment of non-melanoma skin cancer margins using NIRF probes.$877,393
R44 · FY2016 · CA
Along the continuum for an IND: An In-Vivo large animal study for opticalimage guided surgery of spontaneous breast cancer.$801,215
R44 · FY2023 · CA
Intraoperative assessment of non-melanoma skin cancer margins using NIRF probes.$792,080
R44 · FY2015 · CA
An clinical imaging platform for the intraoperative assessment of marginal tissue after BCS resection using in-vivo topical application of a cathepsin-targeted molecular probe$281,748
R43 · FY2019 · CA
TAS::75 0849::TAS SBIR TOPIC 307 PHASE I NOVEL IMAGING AGENTS TO EXPAND THE CLIN$249,912
N43 · FY2011 · CA
Intraoperative assessment of non-melanoma skin cancer margins using NIRF probes.$149,800
R43 · FY2014 · CA